2024 AAAAI/ACAAI Joint Board Review Course
Webcast
37 AMA PRA Category 1 Credits™ OVERVIEW
2024 AAAAI/ACAAI Joint Board Review Course is organized by American Academy of Allergy Asthma & Immunology (AAAAI).
Course opens: April 12, 2024
Course expires: March 31, 2026
Description:
The 2024 AAAAI/ACAAI will be a valuable resource in preparation for certificate exams as well as implementing strong strategies in practice. This course also doubles as a great refresher course for allergy practitioners.
Learning Objectives:
Upon Completions of this activity the participant will be able to:
• Identify, evaluate, and manage current concerns and issues related to the pathophysiology, diagnosis, and treatment of allergic and immunologic diseases
• Demonstrate a mastery of key concepts in allergy and immunology
• Summarize the practical application of key concepts in allergy and immunology in the management of clinical problems
ACCREDITATION & CREDITS
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and (name of non-accredited provider). The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 37.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
TARGET AUDIENCE
PhysicianAllergy & immunologyFellowsSPECIALITIES
Allergy and ImmunologyAsthma Clinical Immunology
Quick Links